Abstract

One of the most prominent symptoms in addiction disorders is the strong desire to consume a particular substance or to show a certain behavior (craving). The strong association between craving and the probability of relapse emphasizes the importance of craving in the therapeutic process. Former studies have demonstrated that neuromodulation using real-time fMRI (rtfMRI) neurofeedback (NF) can be used as a treatment modality in patients with tobacco use disorder. The aim of the present project was to determine whether it is possible to predict the outcome of NF training plus group psychotherapy at the beginning of the treatment. For that purpose, neuronal responses during the first rtfMRI NF session of patients who remained abstinent for at least 3 months were compared to those of patients with relapse. All patients were included in a certified smoke-free course and took part in three NF sessions. During the rtfMRI NF sessions tobacco-associated and neutral pictures were presented. Subjects were instructed to reduce their neuronal responses during the presentation of smoking cues in an individualized region of interest for craving [anterior cingulate cortex (ACC), insula or dorsolateral prefrontal cortex]. Patients were stratified to different groups [abstinence (N = 10) vs. relapse (N = 12)] according to their individual smoking status 3 months after the rtfMRI NF training. A direct comparison of BOLD responses during the first NF-session of patients who had remained abstinent over 3 months after the NF training and patients who had relapsed after 3 months showed that patients of the relapse group demonstrated enhanced BOLD responses, especially in the ACC, the supplementary motor area as well as dorsolateral prefrontal areas, compared to abstinent patients. These results suggest that there is a probability of estimating a successful withdrawal in patients with tobacco use disorder by analyzing the first rtfMRI NF session: a pronounced reduction of frontal responses during NF training in patients might be the functional correlate of better therapeutic success. The results of the first NF sessions could be useful as predictor whether a patient will be able to achieve success after the behavioral group therapy and NF training in quitting smoking or not.

Highlights

  • Smoking tobacco can lead to diverse symptoms and illnesses including cancer, respiratory and cardiovascular diseases and is one of the most significant causes of death in Europe (Ezzati and Lopez, 2003; Sasco et al, 2004; Thun et al, 2013)

  • The regional areas of brain activation associated with craving in nicotine-dependent smokers are scientifically well studied

  • The results suggest that it is feasible for patients with alcohol dependency to reduce their neuronal activity using real-time functional magnetic resonance imaging (rtfMRI) NF (Karch et al, 2015)

Read more

Summary

Introduction

Smoking tobacco can lead to diverse symptoms and illnesses including cancer, respiratory and cardiovascular diseases and is one of the most significant causes of death in Europe (Ezzati and Lopez, 2003; Sasco et al, 2004; Thun et al, 2013). Even with combined medication and cognitive behavioral therapies, the most common outcome 1 year after an attempt to quit is a relapse (Piasecki, 2006). A review about the effectiveness of different medication therapies combined with behavioral support in the United Kingdom showed that abstinence rates were comparable after 3 months with mean values of pooled point prevalence between 35 and 55% (Coleman et al, 2010). The common German cognitive behavioral therapy program called “Rauchfrei Programm” (translation: smoke-free program) showed an abstinence rate of 40% after 6 months and 31% after 1 year (Gradl et al, 2009; Wenig et al, 2013). The regional areas of brain activation associated with craving in nicotine-dependent smokers are scientifically well studied. Functional neuroimaging studies have examined increased craving-related responses, e.g., in the anterior cingulate cortex (ACC) (McClernon et al, 2005; Wilson et al, 2005; Brody et al, 2007; Goudriaan et al, 2010; Hartwell et al, 2011), the medial prefrontal cortex (mPFC) (Hartwell et al, 2011) and the precuneus/cuneus (Smolka et al, 2006; Hartwell et al, 2011) during the presentation of substance-related information, while these areas are linked to attentional processes (Augustus Diggs et al, 2013) and motivation

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call